Discover how RNA, DNA, proteins, lipids, and other biomolecules are revolutionizing our understanding of health, driving drug development, and improving clinical trial outcomes. Protein biomarkers, in particular, play a crucial role in personalized medicine by regulating biological functions and serving as drug targets.

Learn about the breakthroughs in protein signatures that enable earlier diagnoses, identify disease subtypes, and monitor treatment responses. Addressing key challenges in biomarker development, such as ensuring reliable measurements, applying relevant statistical analysis, and utilizing scalable approaches, is essential for advancing from discovery to clinical application.

Watch this informative webinar to understand the critical role of protein biomarkers in advancing personalized medicine and improving clinical trial outcomes.

Our Speakers:

Katarina Hörnaeus, Product Portfolio Director at Olink, part of Thermo Fisher Scientific

Lena Eriksson, Group Manager Assay Development at Olink, part of Thermo Fisher Scientific